The irreversible loss of the dopamine-mediated control of striatal function is considered the functional substrate of the motor symptoms of Parkinson's disease. This pathological event causes a complex rearrangement of neuronal activity which involves specific dopamine-regulated cellular functions and, secondarily, several other cellular properties and transmitter systems. In the present study, we applied recently developed cDNA microarray technology to investigate the genetic correlates of the alterations produced by 6-hydroxydopamine-induced dopamine denervation in the nucleus striatum. We found that chronic dopamine denervation caused the modulation of 50 different genes involved in several cellular functions. In particular, products of the genes modulated by this experimental manipulation are involved both in the intracellular transduction of dopamine signal and in the regulation of glutamate transmission in striatal neurons, providing some information on the possible neuronal events which lead to the reorganization of glutamate transmission in the striatum of parkinsonian rats. 
INTRODUCTION
In Parkinson's disease, the severe neuronal degeneration involving the substantia nigra results in the denervation of dopaminergic terminals in the nucleus striatum, the main recipient of nigral fibers. The irreversible loss of the dopamine-mediated control of striatal function is considered the functional substrate of the motor symptoms of Parkinson's disease and causes a complex rearrangement of neuronal activity which involves specific dopamine-regulated cellular functions and, secondarily, several other cellular properties and transmitter systems (Chase et al., 1998; Calabresi et al., 2000) . A close interaction between the glutamatergic and dopaminergic systems, for example, exists in the striatum (Koetter, 1994; Hersch et al., 1995; Starr, 1995) , and a significant reorganization of glutamatergic transmission occurs in this brain area following chronic dopamine denervation. This can be clearly seen at physiological (Calabresi et al., 1992a (Calabresi et al., , 1993 Centonze et al., 1999a; Tang et al., 2001 ) and behavioral levels (Klockgether & Turski, 1990; Morelli et al., 1992; Papa et al., 1993; Kaur & Starr, 1997) and has been attributed, at least in part, to glutamate receptor alterations in subunit expression, composition, and phosphorylation. In particular, the N-Methyl-daspartate (NMDA) glutamate receptor subunit NR2A has been found to be up-regulated by dopamine denervation of the striatum (Ulas & Cotman, 1996) , whereas the abundance of NR1 and NR2B is significantly decreased (Dunah et al., 2000) . In addition, an increased tyrosine phosphorylation of NMDA recep- 
